Norwegian medical company enters Singapore collaboration to fight virally induced cancer
Zelluna Immunotherapy, a Norwegian company pioneering allogeneic TCR based Natural Killer (TCR-NK) cells for the treatment of cancer, announced a research collaboration agreement with Lion TCR (Singapore) on 24 June …
Norwegian medical company enters Singapore collaboration to fight virally induced cancer Read More